|
Integrated Pharmaceuticals Appoints Richard
Schoenfeld Vice President, Marketing and Business Development
WEDNESDAY, SEPTEMBER 10, 2003 12:08 PM
- PR Newswire
BOSTON, Sep 10, 2003 /PRNewswire-FirstCall
via COMTEX/ -- Integrated Pharmaceuticals, Inc. (INTP.PK)
today announced the appointment of Richard Schoenfeld to the
position of Vice President, Marketing and Business Development.
Schoenfeld will report to Dr. Chinmay Chatterjee, President
and Chief Executive Officer and will be responsible for all
commercial activities, including sales and marketing of the
company's pharmaceutical products, specialty fine chemicals
and ingredients.
Schoenfeld's extensive business development
experience will be an asset to IntePharm's commercial organization,"
said Dr. Chatterjee. "I'm confident that he will help
IntePharm continue to build its specialty pharmaceuticals,
proven therapeutics and fine chemical markets, an important
and promising area of our business."
Schoenfeld's career, prior to joining IntePharm
includes, Director of Marketing at Minnesota Corn Processors
(MCP), managing two existing businesses and two startup businesses
totaling approximately $65 million annual sales. Before MCP
he was Vice President of a specialty ingredient business at
Omega Protein to introduce a new FDA approved nutritional
product, and managed industrial sales.
As President of SVO Specialty Products, he
led the sales growth of this specialty ingredient manufacturer
from startup to over $50 million in revenue. In addition,
Schoenfeld has expertise for expansion of business relationships
with European companies. Prior to SVO Specialty Products,
he led a Danish food ingredient company to over $22 million
sales as they entered the US market.
"I am excited to join IntePharm, given
IntePharm's strong commitment to creative and innovative research
for therapeutic product development and commercial programs,
and I look forward to applying my experience to expand its
customer base," said Schoenfeld.
Schoenfeld obtained a bachelor's degree in
Chemistry from the University of Wisconsin-La Crosse, prior
to starting his career as an analytical chemist at Dow Chemicals.
About the company
Integrated Pharmaceuticals, Inc., is an emerging
pharmaceuticals and biotechnology company that discovers,
develops, manufactures and markets pharmaceuticals, specialty
chemicals and ingredients for significant unmet medical and
commercial needs. Integrated Pharmaceuticals, Inc. is involved
in the application of combined approach of emerging fields
of research in advanced bioprocess engineering, computer simulation
science and metabolic engineering. The Company utilizes these
fields of research for the production of recombinant DNA derived
products for therapeutic uses. IntePharm's clinically active
compounds have applications for the treatment of chronic diseases.
The company has several market ready products in the pipeline
for commercialization in the immediate future.
For further information please contact Dr.
Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. at (978)
696-0020.
SOURCE Integrated Pharmaceuticals, Inc.
Dr. Chinmay Chatterjee of Integrated Pharmaceuticals,
Inc., +1-
978-696-0020
http://www.intepharm.com
|
